? The incidence of acute coronary events is associated with acute thrombotic occlusion of the coronary artery and is likely to result from rupture of the atherosclerotic plaque. The disruption of atheromatous plaque is not necessarily associated with severely obstructive lesions, and the likelihood of plaque rupture is better determined by histologic characteristics. The vulnerable plaques usually demonstrate sizable lipid cores, and thin fibrous caps which are intensely infiltrated by mononuclear cells. Inflammation is directly related to metalloproteinase (MMP) expression and activation in the atherosclerotic plaques, and may constitute the causal link between inflammation and plaque vulnerability. Therefore, radionuclide targeting of MMP 1 production and activity may allow noninvasive detection of the plaques susceptible to rupture. ? ? In the proposed study, indium-1 1 1 -labeled broad-based inhibitor of metalloproteinases (MPI) will be used for the detection of MMP in experimentally-induced atherosclerotic plaques. In addition, technetium-99m- labeled monocyte chemoattractant protein-I (MCP-1) will be employed for targeting of inflammatory burden in atherosclerotic plaques. MPI peptide has broad inhibitory specificity for MMP 1-3, 7-9 and -13 with high inhibitory coefficients, and radiolabeled peptide selectively determines the extent of MMP expression. On the other hand, radiolabeled recombinant human MCP-1, a monomeric 9-1 5 kD polypeptide, specifically binds to MCP-1 receptors on monocytes/macrophages upregulated during recruitment of these cells to the plaque. Experimental models will include lipid-fed rabbits, and genetically altered animals likely to harbor higher degree of monocytic infiltration or MMP production. In addition, diffuse atherosclerotic disease of coronary and carotid arteries will be studied in diabetic swine. Finally, the data obtained from the experimental studies will be translated to develop a clinical diagnostic tool (as a proof of concept) in patients with recent cerebrovascular accidents. The extent of inflammation and MMP expression in the plaques will be ascertained histopathologically. ? (End of Abstract) ? ? ?

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL078681-02
Application #
6950782
Study Section
Special Emphasis Panel (ZHL1-CSR-K (S1))
Program Officer
Buxton, Denis B
Project Start
2004-09-22
Project End
2008-08-31
Budget Start
2005-09-01
Budget End
2006-08-31
Support Year
2
Fiscal Year
2005
Total Cost
$350,667
Indirect Cost
Name
University of California Irvine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
046705849
City
Irvine
State
CA
Country
United States
Zip Code
92697
de Haas, Hans J; Arbustini, Eloisa; Fuster, Valentin et al. (2014) Molecular imaging of the cardiac extracellular matrix. Circ Res 114:903-15
Tekabe, Yared; Li, Qing; Luma, Joane et al. (2010) Noninvasive monitoring the biology of atherosclerotic plaque development with radiolabeled annexin V and matrix metalloproteinase inhibitor in spontaneous atherosclerotic mice. J Nucl Cardiol 17:1073-81
Ohshima, Satoru; Fujimoto, Shinichiro; Petrov, Artiom et al. (2010) Effect of an antimicrobial agent on atherosclerotic plaques: assessment of metalloproteinase activity by molecular imaging. J Am Coll Cardiol 55:1240-9
Ohshima, Satoru; Petrov, Artiom; Fujimoto, Shinichiro et al. (2009) Molecular imaging of matrix metalloproteinase expression in atherosclerotic plaques of mice deficient in apolipoprotein e or low-density-lipoprotein receptor. J Nucl Med 50:612-7
Kramer, Christopher M; Narula, Jagat (2009) Atherosclerotic plaque imaging: the last frontier for cardiac magnetic resonance. JACC Cardiovasc Imaging 2:916-8
Tahara, Nobuhiro; Imaizumi, Tsutomu; Virmani, Renu et al. (2009) Clinical feasibility of molecular imaging of plaque inflammation in atherosclerosis. J Nucl Med 50:331-4
Haider, Nezam; Hartung, Dagmar; Fujimoto, Shinichiro et al. (2009) Dual molecular imaging for targeting metalloproteinase activity and apoptosis in atherosclerosis: molecular imaging facilitates understanding of pathogenesis. J Nucl Cardiol 16:753-62
Schuijf, Joanne D; Achenbach, Stephan; Zoghbi, William A et al. (2009) How to identify the asymptomatic high-risk patient? Curr Probl Cardiol 34:539-77
Fujimoto, Shinichiro; Hartung, Dagmar; Ohshima, Satoru et al. (2008) Molecular imaging of matrix metalloproteinase in atherosclerotic lesions: resolution with dietary modification and statin therapy. J Am Coll Cardiol 52:1847-57
Hartung, Dagmar; Petrov, Artiom; Haider, Nezam et al. (2007) Radiolabeled Monocyte Chemotactic Protein 1 for the detection of inflammation in experimental atherosclerosis. J Nucl Med 48:1816-21

Showing the most recent 10 out of 11 publications